ENDOINFORM
Live / Applied — First extension granted (statement of use) (as of 17 Dec 2025)
What this means for you
Not registered yet, but its 17 Oct 2024 filing date beats anything filed after it. If it registers, the owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 98806393
- Mark type
- Stylized text
- Filed
- 17 Oct 2024
- Published for opposition
- 29 Apr 2025
- Attorney of record
- Melissa Hunter-Ensor
Goods and services
- Class 044 — Medical, beauty and agricultural services: Medical testing for diagnostic or treatment purposes in the field of endometriosis; Medical testing for diagnostic or treatment purposes in the field of oncology; medical testing for diagnostic or treatment purposes in the field of gynecology; medical diagnosis of endometriosis.; medical diagnosis of cancer
Owner
- Aspira Women's Health Inc., Austin, TX, US
- Aspira Women's Health Inc., Austin, TX, US
Prosecution history
- 18 Dec 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 17 Dec 2025 — SOU EXTENSION 1 GRANTED
- 17 Dec 2025 — SOU EXTENSION 1 FILED
- 17 Dec 2025 — SOU TEAS EXTENSION RECEIVED
- 24 Jun 2025 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
- 29 Apr 2025 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 29 Apr 2025 — PUBLISHED FOR OPPOSITION
- 23 Apr 2025 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 01 Apr 2025 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 31 Mar 2025 — ASSIGNED TO EXAMINER
- 31 Mar 2025 — ASSIGNED TO EXAMINER
- 30 Mar 2025 — NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
- 17 Oct 2024 — APPLICATION FILING RECEIPT MAILED
- 17 Oct 2024 — NEW APPLICATION ENTERED